[1] KADAM S S, MAHADIK K R, PARADKAR A R. A process for making agglomerates for use as or in a drug delivery system:India, 183481[P]. 1997-02-14..[2] PAWAR A, PARADKAR A R, KADAM S S, et al. Crystallo-co-ag-glomeration:A novel technique to obtain Ibuprofen-paracetamol agglomerates [J]. AAPS Pharm Sci Tech, 2004, 5(3):1-8.[3] PAWAR A, PARADKAR A R, KADAM S S, et al. Effect of polymers on crystallo-co -agglomeration of ibuprofen-paracetamol:Factorial design [J]. Indian J Pharm Sci, 2007, 69(5):658-664.[4] PAWAR A, PARADKAR A R, KADAM S S, et al. Agglomeration of ibuprofen with talc by novel crystallo-co-agglomeration technique [J]. AAPS Pharm Sci Tech, 2004, 5 (4):1-6.[5] JADHAV N, PAWAR A, PARADKAR A. Design and evaluation of deformable talc agglomerates prepared by crystallo-co-agglomeration technique for generating heterogeneous matrix [J]. AAPS Pharm Sci Tech, 2007, 8(3):1-7.[6] JADHAV N, PAWAR A, PARADKAR A. Effect of drug content and agglomerate size on tabletability and drug release characteristics of bromhexine hydrochloride-talc agglomerates prepared by crystallo-co-agglomeration [J]. Acta Pharm, 2010, 60(1):25-38.[7] MAGHSOODI M, TAGHIZADEH O, MARTIN G P, et al. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique [J]. Int J Pharm, 2008, 351(1-2):45-54.[8] GENIKAL B, RAJENDRA A. Formulation of crystallo-co-agglomerates of naproxen:Study of effect of polymers on drug release [J]. Int J Pharm Tech Res, 2013, 5(3):852-864.[9] NOKHODCHI A, MAGHSOODI M. Preparation of spherical crystal agglomerates of naproxen containing disintegrant for direct tablet making by spherical crystallization technique [J]. AAPS Pharm Sci Tech, 2008, 9(1):54-59.[10] CHAVDA V, MAHESHWARI R K. Tailoring of ketoprofen particle morphology via novel crystallo-co-agglomeration technique to obtain a directly compressible material [J]. Asian J Pharm, 2008, 2(1):61-67.[11] GARALA K, PATEL J, PATEL A, et al. Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo-co-agglomeration [J]. Int J Pharm Investig, 2012, 2(4):189-200.[12] RAVAL M K, SORATHIYA K R, CHAUHAN N P, et al. Influence of polymers/excipients on development of agglomerated crystals of secnidazole by crystallo-co -agglomeration technique to improve processability[J]. Drug Dev Ind Pharm, 2013, 39(3):437-446.[13] KURUMKAR P, DEWANI S, PATHANA I B, et al. Preparation of spherical crystal agglomerates via crystallo-co-agglomeration technique [J]. Digest J Nanomat Biostr, 2012, 7(3):1223-1236.[14] MD S, KHAN K A A, DODDAYYA H, et al. Particle design of aceclofenac-disintegrant agglomerates for direct compression by crystallo-co-agglomeration technique [J]. Asian J Pharm Technol, 2011, 1(2):40-48.[15] SHASHANK A, PRAKASH G S, SANJAY J. Particle design of meloxicam-disintegrant agglomerates for fast dissolution and direct compressibility by crystallo-co-agglomeration technique [J]. Novel Sci Int J Pharm Sci, 2012, 1(6):289-297.[16] YADAV A A, YADAV D S, KAREKAR P S, et al. Enhanced solubility and dissolution rate of olmesartan medoxomil using crystallo-co-agglomeration technique [J]. Der Pharm Sin, 2012, 3(2):160-169.[17] BHATTACHARYA S P, BHATTACHARYA I, PATRO N. Standardistion and optimization of micromeritic properties of nimesulide for processing into tablet dosage form by crystallo-co-agglomeration technology[J]. ASJP, 2010, 4(1):24-27.[18] CHATURVEDI A, SHARMA P K, BANSAL M. A review on recent advancement in crystallo-co-agglomeration [J]. Adv Biologic Res, 2011, 5(6):273-281.[19] THATI J, RASMUSON A. On the mechanisms of formation of spherical agglomerates [J]. Eur J Pharm Sci, 2011, 42(4):365-379.[20] RAHATE N B, BODHANKAR M M, DHOKE P N. Crystallo-co-agglomeration:A novel technique to improve flow and compressibility [J]. J Drug Delive Therapeut, 2013, 3(4):178-183.[21] MAGHSOODI M. Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique[J]. Pharm Develop Technol, 2011,16(5):474-482.[22] JOLLY C M, LEKSHMI P, CONSTANTINE L, et al. Crystallo-co-agglomeration:An innovative technique for size enlargement and improved flow properties of powders [J]. Res Rev:J Mate Sci, 2013, 2(1):1-14.[23] AMARO-GONZALEZ D, BISCANS B. Spherical agglomeration during crystallization of an active pharmaceutical ingredient [J]. Powder Technol, 2002, 128(2):188-194.[24] CHOW A H L, LEUNG M W M. A study of the mechanisms of wet spherical agglomeration of pharmaceutical powders [J]. Drug Dev Ind Pharm, 1996, 22(4):357-371.[25] PARADKAR A R, PAWAR A P, JADHAV N R. Crystallo-co-agglomeration:A novel particle engineering technique [J]. Asian J Pharm, 2010, 4(1):4-10.[26] GARALA K, PATEL J, PATEL A, et al. Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration:An integrated approach of principal component analysis and Box-Behnken experimental design [J]. Int J Pharm, 2013, 452(1-2):135-156.[27] PATIL S V, SAHOO S K. Pharmaceutical overview of spherical crystallization [J]. Der Pharm Lett, 2010, 2(1):421-426.[28] PARIDA R. Evaluation parameters for spherical agglomerates formed by spherical crystallization technique[J].Int J Pharm Biol Sci, 2010, 1(3):1-10.[29] YADHAV A, YADHAV V. Directly compressible roxithromycin recrystallised agglomerates by solvent change method[J]. Der Pharm Lett, 2010, 2(1):25-40.[30] GOYAL N K, SHARMA N, SHARMA P K. Spherical crystallization:A method for improving powder and tablet characterstics[J]. Der Pharm Lett, 2010, 2(4):226-234.[31] YANG M S, CUI F D. Advances of spherical crystallization technique in pharmaceutical particle design[J]. Chin Pharm J(中国药学杂志), 2004, 39(2):85-89.